Altermune Technologies

Business Data, Corporate Office and Headquarter Address

About

Altermune Technologies is Therapeutic Devices in United States that focus on Provider business. Founded in 2010. They cover business area such as Provider, therapeutic service, resistant pathogen, alphamer, life-threaten infectious disease.

Business Type

Therapeutic Devices

Country

United States

Founded

2010
( 14 years old in 2024 )

Company Focus

Provider

Website

-

Corporate Office and Headquarter Office address:

2875 Michelle Drive
Suite 300
Irvine, CA 92606
United States

Phone number:

Private

Office Opening Hours*:

Monday 9.30 - 17.00
Tuesday 9.30 - 17.00
Wednesday 9.30 - 17.00
Thursday 9.30 - 17.00
Friday 9.30 - 17.00
Saturday Closed
Sunday Closed

Business Coverage

Providertherapeutic serviceresistant pathogenalphamerlife-threaten infectious disease

* We use standard office opening hours in near Altermune Technologies's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.

Altermune Technologies Frequently Asked Questions

What or who is Altermune Technologies?

Altermune Technologies is Therapeutic Devices business from United States that founded in 2010 (14 years old in 2024), Altermune Technologies business is focusing on Provider.

Where is Altermune Technologies headquarter and corporate office address?

Altermune Technologies headquarter office and corporate office address is located in 2875 Michelle Drive Suite 300 Irvine, CA 92606 United States.

Where is Altermune Technologies country origins?

Altermune Technologies was founded in United States.

What is Provider business focus on?

In 2024, Altermune Technologies is currently focus on Provider sector.

Provider Business Interest from Google Trend

Above is snippet of Google Trends for "Provider" term, if you have problem loading the snippet, please visit here: Google Trend.

Disclaimer: This website is not affiliated with Altermune Technologies, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.